2015
DOI: 10.1007/s00270-015-1113-4
|View full text |Cite
|
Sign up to set email alerts
|

Use of a New Hybrid Heparin-Bonded Nitinol Ring Stent in the Popliteal Artery: Procedural and Mid-term Clinical and Anatomical Outcomes

Abstract: The TIGRIS hybrid heparin-bonded nitinol ring stent is a safe and effective endovascular option for complex occlusive disease of the popliteal artery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
7
0
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 25 publications
1
7
0
2
Order By: Relevance
“…The use of hybrid heparin-bonded, nitinol ring stents showed a primary patency of 69.5e79% at 12 months of follow-up for the popliteal artery lesions. 19,20 The primary patency obtained in our study reflects better results with the use of nitinol interwoven stents (89.6%).…”
Section: Discussionsupporting
confidence: 62%
“…The use of hybrid heparin-bonded, nitinol ring stents showed a primary patency of 69.5e79% at 12 months of follow-up for the popliteal artery lesions. 19,20 The primary patency obtained in our study reflects better results with the use of nitinol interwoven stents (89.6%).…”
Section: Discussionsupporting
confidence: 62%
“…The reported 1-year primary patency rates of the Supera stent in the popliteal artery ranged between 68.4% and 88%, while the observed rate with the popliteal TIGRIS stents (W. L. Gore & Associates) at 12 months was 69.5%. [2][3][4]26,27 However, optimal deployment of the Supera stent remains crucial as stent elongation or intussusception is associated with loss of radial strength and higher rates of restenosis. 1,28 Up to now there has been no clear solution concerning ISR, while popliteal stent occlusion is associated with loss of a bypass target.…”
Section: Discussionmentioning
confidence: 99%
“…However, the development of new-generation devices improved the results of stent therapy in this anatomical territory, but impaired arterial remodeling and interference with future surgical options are disadvantages. [2][3][4][5] Additionally, in the absence of clear-cut solutions, in-stent restenosis (ISR) remains a challenging complication of infrainguinal peripheral artery disease (PAD) treatment. 6 The "leave nothing behind" strategies, namely, drugcoated balloon (DCB) angioplasty and combined directional atherectomy and antirestenotic therapy (DAART), can theoretically overcome the problems caused by the mobility of the knee joint.…”
Section: Introductionmentioning
confidence: 99%
“…La serie de Parthipun y cols. (18) recoge 50 lesiones tratadas con stent dual en la región poplítea. En su caso, el 74% de las lesiones fueron oclusiones completas, algo superior a la mayoría de los estudios.…”
Section: Discussionunclassified